Parallel Advisors’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-409
| Closed | – | – | 2813 |
|
|
2019
Q4 | $0 | Hold |
409
| – | – | ﹤0.01% | 2592 |
|
|
2019
Q3 | $0 | Hold |
409
| – | – | ﹤0.01% | 2600 |
|
|
2019
Q2 | $0 | Hold |
409
| – | – | ﹤0.01% | 2542 |
|
|
2019
Q1 | $0 | Hold |
409
| – | – | ﹤0.01% | 2496 |
|
|
2018
Q4 | $0 | Sell |
409
-7
| -2% | -$3 | ﹤0.01% | 2448 |
|
|
2018
Q3 | $0 | Hold |
416
| – | – | ﹤0.01% | 2382 |
|
|
2018
Q2 | $0 | Hold |
416
| – | – | ﹤0.01% | 2312 |
|
|
2018
Q1 | $0 | Hold |
416
| – | – | ﹤0.01% | 2285 |
|
|
2017
Q4 | $0 | Hold |
416
| – | – | ﹤0.01% | 2213 |
|
|
2017
Q3 | $0 | Sell |
416
-400
| -49% | -$148 | ﹤0.01% | 2368 |
|
|
2017
Q2 | $0 | Hold |
816
| – | – | ﹤0.01% | 2326 |
|
|
2017
Q1 | $0 | Buy |
816
+4
| +0.5% | +$2 | ﹤0.01% | 2184 |
|
|
2016
Q4 | $0 | Buy |
+812
| New | +$275 | ﹤0.01% | 1819 |
|
Parallel Advisors's GCVRZ Position: Q1 2020 in Review
Parallel Advisors sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 409 shares.
Parallel Advisors first reported a position in GCVRZ in Q4 2016 and held it in 13 quarters. The position peaked at $0 in Q4 2019. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.
- Parallel Advisors reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
- Parallel Advisors sold 409 Sanofi Contingent Value Rights shares in Q1 2020.
- Parallel Advisors first reported a position in Sanofi Contingent Value Rights in Q4 2016 and held it in 13 quarters.
- Parallel Advisors's Sanofi Contingent Value Rights position peaked at $0 in Q4 2019.
- 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.
Based on Parallel Advisors's 13F filing for Q1 2020, filed 27 Apr 2020.